NewsBrian Armstrong’s NewLimit Raises $435M for Human TrialsadminJune 3, 2026 by adminJune 3, 202604 NewLimit, a longevity biotech startup co-founded by Coinbase CEO Brian Armstrong, has raised $435 million in Series C funding to move its first age-reprogramming medicine...
